Top

Published in:

01-06-2014 | Editorial

An ALTernate Interpretation of Serum Transaminases

Authors: Joseph Alcorn, Michael J. Crossey

Published in: Digestive Diseases and Sciences | Issue 6/2014

Excerpt

In this issue, Hee Yeon Kim et al. [1] further extend an evolving understanding of ALT reference range in ways that affirm the importance of conceiving of laboratory data as probability estimates influenced by clinical circumstances. Furthermore, their work also demonstrates latent clinical information in laboratory data that outdated methods of reporting leave untapped but which an “intelligent” medical laboratory could provide. …

Kim HY, Kim CW, Lee CD, et al. Can “Healthy” normal alanine aminotransferase levels identify the metabolically obese phenotype? Dig Dis Sci. (Epub ahead of print). doi:10.1007/s10620-013-2995-0

Sherman KE. Alanine aminotransferase in clinical practice. Arch Intern Med. 1991;151:260–265.PubMedCrossRef

Dong MH, Bettencourt R, Barrett-Connor E, et al. Alanine aminotransferase decreases with age: the rancho Bernardo study. PLoS ONE. 2010;5(12):314254. doi:10.1371/journal.pone.0014254.

Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137:1–9.PubMedCrossRef

Schwimmer JB, Gregory WD, Norman J, et al. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology. 2010;138:1357–1364.PubMedCentralPubMedCrossRef

Thomsen M, Nordestgaard BG. Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome. JAMA Intern Med. 2014;174(1):15–22.PubMedCrossRef

Black ER. Diagnostic strategies and test algorithms in liver disease. Clin Chem. 1997;43:1555–1560.PubMed

Modernising Pathology Services is available on the department’s website at: www.dh.gov.uk/pathologymodernisation, 2004, p 7.

Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518–526.PubMedCrossRef

10.

Lin Z-H, Xin Y-N, Dong Q-J, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011;53:726–736.PubMedCrossRef

11.

Meyer NJ. Future clinical applications of genomics for acute respiratory distress syndrome. Lancet Respir Med. 2013;1:793–803.PubMedCrossRef

12.

Rossolatos D, Aitchison KJ. Genomics for clinical utility: the future is near. Genome Med. 2014;6:3. http://genomemedicine.com/content/6/1/3.

Title: An ALTernate Interpretation of Serum Transaminases
Authors: Joseph Alcorn
Michael J. Crossey
Publication date: 01-06-2014
Publisher: Springer US
Published in: Digestive Diseases and Sciences / Issue 6/2014
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-014-3123-5

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

An ALTernate Interpretation of Serum Transaminases

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2014

Clinical Impact of Predicting CCND1 Amplification Using Plasma DNA in Superficial Esophageal Squamous Cell Carcinoma

Patients Who Avoid Wheat and Gluten: Is That Health or Lifestyle?

Adiponectin Inhibits Murine Pancreatic Cancer Growth

Cost-Effectiveness of Chemoprevention with Proton Pump Inhibitors in Barrett’s Esophagus

From Ischochymia to Gastroparesis: Proposed Mechanisms and Preferred Management of Dyspepsia Over the Centuries

Characteristics of Patients Who Avoid Wheat and/or Gluten in the Absence of Celiac Disease

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page